Results 171 to 180 of about 22,968 (195)

Palbociclib

Reactions Weekly, 2022
  +7 more sources

Palbociclib

Reactions Weekly, 2020
  +8 more sources

Palbociclib

Reactions Weekly, 2019
  +9 more sources

Palbociclib

Reactions Weekly, 2023
  +5 more sources

Palbociclib

Reactions Weekly
  +7 more sources

Palbociclib

Reactions Weekly, 2018
  +5 more sources

Switch to fulvestrant and palbociclib versus no switch in advanced breast cancer with rising ESR1 mutation during aromatase inhibitor and palbociclib therapy (PADA-1): a randomised, open-label, multicentre, phase 3 trial

Lancet Oncology, The, 2022
Renaud Sabatier, Florian Clatot, Céline Callens   +2 more
exaly  

Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study

Lancet Oncology, The, 2021
Erica L Mayer, Miguel Martin, Gabor Rubovszky   +2 more
exaly  

Overall Survival with Palbociclib and Fulvestrant in Advanced Breast Cancer

New England Journal of Medicine, 2018
Igor N Bondarenko, Seock-Ah Im, Norikazu Masuda   +2 more
exaly  

Palbociclib and Letrozole in Advanced Breast Cancer

New England Journal of Medicine, 2016
Miguel Martin, Hope S Rugo, Seock-Ah Im
exaly